Stepwise Pharmacologic Management of Headache When Acetaminophen Is Inadequate

Adding an NSA ID to Acetaminophen

For patients whose headache persists despite optimal acetaminophen dosing, adding an NSA ID (e.g., ibuprofen 400 mg, naproxen 500 mg, diclofenac, or aspirin) is recommended as the next therapeutic step. 1
Ibuprofen 400 mg has demonstrated efficacy for tension‑type headaches. 3
Combining acetaminophen with an NSA ID provides greater pain relief than either agent alone. 1

When acetaminophen ± NSA ID fails to relieve moderate‑to‑severe headache pain, adding a triptan (any class member) creates an effective combination therapy. 2
Combination therapy (triptan + NSA ID or triptan + acetaminophen) yields superior pain relief compared with triptan monotherapy. 4
Specifically, triptan + NSA ID results in approximately 130 additional patients per 1,000 achieving sustained pain relief at 48 hours versus triptan alone. 5
Triptan + acetaminophen shows directionally favorable outcomes across all measured benefits. 4

All approved triptans (sumatriptan, rizatriptan, eletriptan, almotriptan, naratriptan, frovatriptan, zolmitriptan) are viable options. 6
Choice of triptan should consider route of administration (oral, nasal spray, subcutaneous), cost, and individual patient response. 6
Patients who do not respond to one triptan may achieve relief with another triptan within the same class. 6

For patients who remain symptomatic after combination therapy with a triptan and an NSA ID or acetaminophen, CGRP receptor antagonists (gepants) such as rimegepant, ubrogepant, or zavegepant are appropriate alternatives. 6
Gepants are indicated for moderate‑to‑severe episodic migraine when standard analgesic combinations are insufficient. 6
Lasmiditan (a ditan) is reserved for individuals who have failed all other recommended treatments. 6

Tension‑type headache: First‑line therapy includes ibuprofen 400 mg or acetaminophen 1000 mg. 3
Migraine: Follow the stepwise approach outlined above, emphasizing early use of triptans. 2

Opioids and butalbital‑containing compounds should never be used for routine headache management. 1
To prevent medication‑overuse headache, limit NSA ID use to ≤ 15 days per month and triptan use to ≤ 10 days per month. 6
Initiate treatment as early as possible in the headache attack to maximize efficacy. 1
Antiemetics (e.g., metoclopramide, prochlorperazine) are recommended when nausea or vomiting is prominent. 1

Nasal spray or subcutaneous triptans are preferred when severe nausea or vomiting impedes oral drug absorption. 1

When multiple therapeutic options exist, select the less costly, guideline‑recommended medication. 6
Generic NSA IDs and older triptans (sumatriptan, rizatriptan) are generally more affordable than newer gepants. 1

Encourage patients to maintain adequate hydration, regular meals, consistent sleep patterns, and routine aerobic exercise. 6
Identify and address modifiable headache triggers as part of comprehensive care. 6